Literature DB >> 26912620

Mammalian Pathogenesis and Transmission of H7N9 Influenza Viruses from Three Waves, 2013-2015.

Jessica A Belser1, Hannah M Creager1,2, Xiangjie Sun1, Kortney M Gustin1, Tara Jones3, Wun-Ju Shieh3, Taronna R Maines1, Terrence M Tumpey4.   

Abstract

UNLABELLED: Three waves of human infection with H7N9 influenza viruses have concluded to date, but only viruses within the first wave (isolated between March and September 2013) have been extensively studied in mammalian models. While second- and third-wave viruses remain closely linked phylogenetically and antigenically, even subtle molecular changes can impart critical shifts in mammalian virulence. To determine if H7N9 viruses isolated from humans during 2013 to 2015 have maintained the phenotype first identified among 2013 isolates, we assessed the ability of first-, second-, and third-wave H7N9 viruses isolated from humans to cause disease in mice and ferrets and to transmit among ferrets. Similar to first-wave viruses, H7N9 viruses from 2013 to 2015 were highly infectious in mice, with lethality comparable to that of the well-studied A/Anhui/1/2013 virus. Second- and third-wave viruses caused moderate disease in ferrets, transmitted efficiently to cohoused, naive contact animals, and demonstrated limited transmissibility by respiratory droplets. All H7N9 viruses replicated efficiently in human bronchial epithelial cells, with subtle changes in pH fusion threshold identified between H7N9 viruses examined. Our results indicate that despite increased genetic diversity and geographical distribution since their initial detection in 2013, H7N9 viruses have maintained a pathogenic phenotype in mammals and continue to represent an immediate threat to public health. IMPORTANCE: H7N9 influenza viruses, first isolated in 2013, continue to cause human infection and represent an ongoing public health threat. Now entering the fourth wave of human infection, H7N9 viruses continue to exhibit genetic diversity in avian hosts, necessitating continuous efforts to monitor their pandemic potential. However, viruses isolated post-2013 have not been extensively studied, limiting our understanding of potential changes in virus-host adaptation. In order to ensure that current research with first-wave H7N9 viruses still pertains to more recently isolated strains, we compared the relative virulence and transmissibility of H7N9 viruses isolated during the second and third waves, through 2015, in the mouse and ferret models. Our finding that second- and third-wave viruses generally exhibit disease in mammals comparable to that of first-wave viruses strengthens our ability to extrapolate research from the 2013 viruses to current public health efforts. These data further contribute to our understanding of molecular determinants of pathogenicity, transmissibility, and tropism.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26912620      PMCID: PMC4836344          DOI: 10.1128/JVI.00134-16

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  59 in total

1.  The first case of H7N9 influenza in Taiwan.

Authors:  Sui-Yuan Chang; Pi-Han Lin; Jen-Chih Tsai; Chien-Ching Hung; Shan-Chwen Chang
Journal:  Lancet       Date:  2013-04-29       Impact factor: 79.321

2.  Lack of transmission of H5N1 avian-human reassortant influenza viruses in a ferret model.

Authors:  Taronna R Maines; Li-Mei Chen; Yumiko Matsuoka; Hualan Chen; Thomas Rowe; Juan Ortin; Ana Falcón; Tran Hien Nguyen; Le Quynh Mai; Endang R Sedyaningsih; Syahrial Harun; Terrence M Tumpey; Ruben O Donis; Nancy J Cox; Kanta Subbarao; Jacqueline M Katz
Journal:  Proc Natl Acad Sci U S A       Date:  2006-07-31       Impact factor: 11.205

3.  Differences in the Epidemiology of Human Cases of Avian Influenza A(H7N9) and A(H5N1) Viruses Infection.

Authors:  Ying Qin; Peter W Horby; Tim K Tsang; Enfu Chen; Lidong Gao; Jianming Ou; Tran Hien Nguyen; Tran Nhu Duong; Viktor Gasimov; Luzhao Feng; Peng Wu; Hui Jiang; Xiang Ren; Zhibin Peng; Sa Li; Ming Li; Jiandong Zheng; Shelan Liu; Shixiong Hu; Rongtao Hong; Jeremy J Farrar; Gabriel M Leung; George F Gao; Benjamin J Cowling; Hongjie Yu
Journal:  Clin Infect Dis       Date:  2015-05-04       Impact factor: 9.079

4.  Risk factors for influenza A(H7N9) disease--China, 2013.

Authors:  Bo Liu; Fiona Havers; Enfu Chen; Zhengan Yuan; Hui Yuan; Jianming Ou; Mei Shang; Kai Kang; Kaiju Liao; Fuqiang Liu; Dan Li; Hua Ding; Lei Zhou; Weiping Zhu; Fan Ding; Peng Zhang; Xiaoye Wang; Jianyi Yao; Nijuan Xiang; Suizan Zhou; Xiaoqin Liu; Ying Song; Hualin Su; Rui Wang; Jian Cai; Yang Cao; Xianjun Wang; Tian Bai; Jianjun Wang; Zijian Feng; Yanping Zhang; Marc-Alain Widdowson; Qun Li
Journal:  Clin Infect Dis       Date:  2014-06-13       Impact factor: 9.079

5.  Single amino acid substitutions in influenza haemagglutinin change receptor binding specificity.

Authors:  G N Rogers; J C Paulson; R S Daniels; J J Skehel; I A Wilson; D C Wiley
Journal:  Nature       Date:  1983 Jul 7-13       Impact factor: 49.962

6.  Infection of inbred BALB/c and C57BL/6 and outbred Institute of Cancer Research mice with the emerging H7N9 avian influenza virus.

Authors:  Zhaoqin Zhu; Yuqin Yang; Yanling Feng; Bisheng Shi; Lixiang Chen; Ye Zheng; Di Tian; Zhigang Song; Chunhua Xu; Boyin Qin; Xiaonan Zhang; Wencai Guan; Fang Liu; Tao Yang; Hua Yang; Dong Zeng; Wenjiang Zhou; Yunwen Hu; Xiaohui Zhou
Journal:  Emerg Microbes Infect       Date:  2013-08-07       Impact factor: 7.163

7.  Transmission of H7N9 influenza virus in mice by different infective routes.

Authors:  Linlin Bao; Lili Xu; Hua Zhu; Wei Deng; Ting Chen; Qi Lv; Fengdi Li; Jing Yuan; Yanfeng Xu; Lan Huang; Yanhong Li; Jiangning Liu; Yanfeng Yao; Pin Yu; Honglin Chen; Chuan Qin
Journal:  Virol J       Date:  2014-11-03       Impact factor: 4.099

8.  Amino acids substitutions in the PB2 protein of H7N9 influenza A viruses are important for virulence in mammalian hosts.

Authors:  Seiya Yamayoshi; Satoshi Fukuyama; Shinya Yamada; Dongming Zhao; Shin Murakami; Ryuta Uraki; Tokiko Watanabe; Yuriko Tomita; Gabriele Neumann; Yoshihiro Kawaoka
Journal:  Sci Rep       Date:  2015-01-27       Impact factor: 4.379

9.  Influenza HA subtypes demonstrate divergent phenotypes for cleavage activation and pH of fusion: implications for host range and adaptation.

Authors:  Summer E Galloway; Mark L Reed; Charles J Russell; David A Steinhauer
Journal:  PLoS Pathog       Date:  2013-02-14       Impact factor: 6.823

10.  Mutations in haemagglutinin that affect receptor binding and pH stability increase replication of a PR8 influenza virus with H5 HA in the upper respiratory tract of ferrets and may contribute to transmissibility.

Authors:  Holly Shelton; Kim L Roberts; Eleonora Molesti; Nigel Temperton; Wendy S Barclay
Journal:  J Gen Virol       Date:  2013-03-13       Impact factor: 3.891

View more
  12 in total

1.  Identification of key hemagglutinin residues responsible for cleavage, acid stability, and virulence of fifth-wave highly pathogenic avian influenza A(H7N9) viruses.

Authors:  Xiangjie Sun; Jessica A Belser; Hua Yang; Joanna A Pulit-Penaloza; Claudia Pappas; Nicole Brock; Hui Zeng; Hannah M Creager; James Stevens; Taronna R Maines
Journal:  Virology       Date:  2019-07-12       Impact factor: 3.616

2.  Role of H7 hemagglutinin in murine infectivity of influenza viruses following ocular inoculation.

Authors:  Jessica A Belser; Xiangjie Sun; Hannah M Creager; Adam Johnson; Callie Ridenour; Li-Mei Chen; Terrence M Tumpey; Taronna R Maines
Journal:  Virology       Date:  2016-12-10       Impact factor: 3.616

Review 3.  A Guide for the Use of the Ferret Model for Influenza Virus Infection.

Authors:  Jessica A Belser; Alissa M Eckert; Thanhthao Huynh; Joy M Gary; Jana M Ritter; Terrence M Tumpey; Taronna R Maines
Journal:  Am J Pathol       Date:  2019-10-23       Impact factor: 4.307

4.  Risk Assessment of Fifth-Wave H7N9 Influenza A Viruses in Mammalian Models.

Authors:  Xiangjie Sun; Jessica A Belser; Claudia Pappas; Joanna A Pulit-Penaloza; Nicole Brock; Hui Zeng; Hannah M Creager; Shoshona Le; Malania Wilson; Amanda Lewis; Thomas J Stark; Wun-Ju Shieh; John Barnes; Terrence M Tumpey; Taronna R Maines
Journal:  J Virol       Date:  2018-12-10       Impact factor: 5.103

Review 5.  Hemagglutinin Stability and Its Impact on Influenza A Virus Infectivity, Pathogenicity, and Transmissibility in Avians, Mice, Swine, Seals, Ferrets, and Humans.

Authors:  Charles J Russell
Journal:  Viruses       Date:  2021-04-24       Impact factor: 5.048

6.  Genetic Characterization of Continually Evolving Highly Pathogenic H5N6 Influenza Viruses in China, 2012-2016.

Authors:  Meng Li; Na Zhao; Jing Luo; Yuan Li; Lin Chen; Jiajun Ma; Lin Zhao; Guohui Yuan; Chengmin Wang; Yutian Wang; Yanhua Liu; Hongxuan He
Journal:  Front Microbiol       Date:  2017-02-28       Impact factor: 5.640

7.  Variability in H9N2 haemagglutinin receptor-binding preference and the pH of fusion.

Authors:  Thomas P Peacock; Donald J Benton; Jean-Remy Sadeyen; Pengxiang Chang; Joshua E Sealy; Juliet E Bryant; Stephen R Martin; Holly Shelton; John W McCauley; Wendy S Barclay; Munir Iqbal
Journal:  Emerg Microbes Infect       Date:  2017-03-22       Impact factor: 7.163

Review 8.  The structural variability of the influenza A hemagglutinin receptor-binding site.

Authors:  Michal Lazniewski; Wayne K Dawson; Teresa Szczepinska; Dariusz Plewczynski
Journal:  Brief Funct Genomics       Date:  2018-11-26       Impact factor: 4.241

Review 9.  The Pandemic Threat of Emerging H5 and H7 Avian Influenza Viruses.

Authors:  Troy C Sutton
Journal:  Viruses       Date:  2018-08-28       Impact factor: 5.048

10.  Rapid, reliable, and reproducible cell fusion assay to quantify SARS-Cov-2 spike interaction with hACE2.

Authors:  Min Zhao; Pei-Yi Su; Danielle A Castro; Therese N Tripler; Yingxia Hu; Matthew Cook; Albert I Ko; Shelli F Farhadian; Benjamin Israelow; Charles S Dela Cruz; Yong Xiong; Richard E Sutton
Journal:  PLoS Pathog       Date:  2021-06-24       Impact factor: 7.464

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.